Bath & Body Works (BBWI) has quietly slipped this year, with the stock down almost 50% year to date even as earnings and cash generation remain relatively steady. That disconnect is drawing value focused investors back in.
Despite the steep year to date share price decline and a three year total shareholder return of negative 52.4%, recent strength, including a 9.4% seven day share price return, suggests bearish momentum may be starting to ease as investors reassess the risk reward trade off.
With profits holding up, a sizeable discount to analyst targets and shares still under pressure, the key question now is whether Bath & Body Works is a genuine value opportunity or if the market is rightly discounting future growth.
Most Popular Narrative Narrative: 53.3% Undervalued
With Bath & Body Works last closing at $19.01 and the narrative fair value at $40.73, Zwfis is arguing the market is missing a big recovery story.
I do not think BBWI is a stock that will blow up like crazy in the next 1 to 2 years. But I do think it will make some modest improvements through the next couple of years; especially because in their guidance that they provided, it was included that numbers were anticipating tariffs, so I believe that the numbers that they priced in might actually be lower then what will actually happen.
Curious how modest near term improvements could still justify such a large upside? The narrative leans on powerful cash flow growth, rising margins and a higher future earnings multiple. Want to see how those pieces fit together into that bold fair value?
Result: Fair Value of $40.73 (UNDERVALUED)
However, lingering debt from the Victoria’s Secret split and uncertainty around executing international and mens segment expansion could easily derail this bullish recovery case.
Build Your Own Bath & Body Works Narrative
If this perspective does not quite fit your view or you prefer digging into the numbers yourself, you can spin up a personal narrative in under three minutes.
A great starting point for your Bath & Body Works research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.